Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kovacaine Mist for Maxillary Dental Anesthesia
NCT01479517Phase 2Completed
- Sponsor
- St. Renatus, LLC
- Start
- Jan 2012
- Primary completion
- Apr 2012
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tetracaine HCl + oxymetazoline HCl in dental anesthesia (3 arms), sponsored by St. Renatus, LLC. Primary endpoint: Proportion of Subjects Receiving Kovacaine Mist Who do Not Require Rescue Anesthesia During the Operative Dental Procedure at 15 months. Started Jan 2012; status: completed.
02
Drugs
tetracaine HCl + oxymetazoline HCl
03
Conditions
dental anesthesia
Beyond the preview
Go deeper on NCT01479517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479517.